Overexpression of MET is a new predictive marker for anti-EGFR therapy in metastatic colorectal cancer with wild-type KRAS

被引：0
|
作者：
Tomokazu Kishiki
Hiroaki Ohnishi
Tadahiko Masaki
Kouki Ohtsuka
Yasuo Ohkura
Jyunji Furuse
Takashi Watanabe
Masanori Sugiyama
机构：
[1] Kyorin University School of Medicine,Department of Surgery
[2] Kyorin University School of Medicine,Department of Laboratory Medicine
[3] Kyorin University School of Medicine,Department of Pathology
[4] Kyorin University School of Medicine,Department of Medical Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 73卷
关键词：
Colorectal cancer; PTEN; MET; Anti-EGFR therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：749 / 757
页数：8
相关论文
共 50 条
  • [1] Overexpression of MET is a new predictive marker for anti-EGFR therapy in metastatic colorectal cancer with wild-type KRAS
    Kishiki, Tomokazu
    Ohnishi, Hiroaki
    Masaki, Tadahiko
    Ohtsuka, Kouki
    Ohkura, Yasuo
    Furuse, Jyunji
    Watanabe, Takashi
    Sugiyama, Masanori
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (04) : 749 - 757
  • [2] New predictive marker for anti-EGFR therapy in metastatic colorectal cancer with wild-type KRAS
    Kishiki, Tomokazu
    Masaki, Tadahiko
    Matsuoka, Hiroyoshi
    Kojima, Koichiro
    Asoh, Nobuyoshi
    Beniya, Ayumi
    Sakamoto, Yoshihiro
    Mori, Toshiyuki
    Abe, Nobutsugu
    CANCER SCIENCE, 2018, 109 : 1378 - 1378
  • [3] Biomarkers and anti-EGFR therapies for KRAS wild-type metastatic colorectal cancer
    Jose A. García-Sáenz
    Javier Sastre
    Eduardo Díaz-Rubio García
    Clinical and Translational Oncology, 2009, 11 : 737 - 747
  • [4] Biomarkers and anti-EGFR therapies for KRAS wild-type metastatic colorectal cancer
    Garcia-Saenz, Jose A.
    Sastre, Javier
    Diaz-Rubio Garcia, Eduardo
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (11): : 737 - 747
  • [5] EGFR Protein Expression of KRAS Wild-Type Colorectal Cancer: Predictive Value of the Sidedness for Efficacy of Anti-EGFR Therapy
    Uhlyarik, A.
    Piurko, V
    Vizkeleti, L.
    Papai, Zs
    Raso, E.
    Lahm, E.
    Kiss, E.
    Sikter, M.
    Vachaja, J.
    Kenessey, I
    Timar, Jozsef
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (03) : 1429 - 1434
  • [6] BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer
    Chen Mao
    Ru-Yan Liao
    Qing Chen
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1293 - 1294
  • [7] BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer
    Mao, Chen
    Liao, Ru-Yan
    Chen, Qing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (08) : 1293 - 1294
  • [8] PREDICTIVE MOLECULAR BIOMARKERS IN COLORECTAL CANCER: IS KRAS AND BRAF WILD TYPE STATUS REQUIRED FOR ANTI-EGFR THERAPY?
    Marchoudi, N.
    Joutei, H. Amrani Hassani
    Jouali, F.
    Fekkak, J.
    Rhaissi, H.
    ANTICANCER RESEARCH, 2014, 34 (10) : 6048 - 6048
  • [9] AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer
    Cardone, Claudia
    Blauensteiner, Bernadette
    Moreno-Viedma, Veronica
    Martini, Giulia
    Simeon, Vittorio
    Vitiello, Pietro P.
    Ciardiello, Davide
    Belli, Valentina
    Matrone, Nunzia
    Troiani, Teresa
    Morgillo, Floriana
    Marino, Federica Zito
    Dentice, Monica
    Nappi, Annarita
    Boccaccino, Alessandra
    Antoniotti, Carlotta
    Cremolini, Chiara
    Pietrantonio, Filippo
    Prager, Gerald W.
    Normanno, Nicola
    Maiello, Evaristo
    Argiles, Guillem
    Elez, Elena
    Signoriello, Giuseppe
    Franco, Renato
    Falcone, Alfredo
    Tabernero, Josep
    Sibilia, Maria
    Ciardiello, Fortunato
    Martinelli, Erika
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : 1 - 10
  • [10] MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAF
    Mosakhani, Neda
    Lahti, Leo
    Borze, Ioana
    Karjalainen-Lindsberg, Marja-Liisa
    Sundstrom, Jari
    Ristamaki, Raija
    Osterlund, Pia
    Knuutila, Sakari
    Sarhadi, Virinder Kaur
    CANCER GENETICS, 2012, 205 (11) : 545 - 551
12345